Lamivudine and famciclovir combination therapy with or without addition of IFN-alfa-2b for HBeAg positive chronic hepatitis B

被引：0
|
作者：
Sangfelt, BP
Uhnoo, I
Hollander, A
Lindh, G
Weiland, O
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Univ Uppsala Hosp, Uppsala, Sweden
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1867
引用
收藏
页码：630A / 630A
页数：1
相关论文
共 50 条
  • [21] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Teerha Piratvisuth
    George Lau
    You-Chen Chao
    Rui Jin
    Anuchit Chutaputti
    Q.-B. Zhang
    Tawesak Tanwandee
    Peter Button
    Matei Popescu
    Hepatology International, 2008, 2 : 102 - 110
  • [22] Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    Piratvisuth, Teerha
    Lau, George
    Chao, You-Chen
    Jin, Rui
    Chutaputti, Anuchit
    Zhang, Q. -B.
    Tanwandee, Tawesak
    Button, Peter
    Popescu, Matei
    HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 102 - 110
  • [23] Relapse in HBeAg-positive chronic hepatitis B after peg-interferon alpha-2b therapy alone or in combination with lamivudine
    Flink, HJ
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HL
    HEPATOLOGY, 2005, 42 (04) : 588A - 588A
  • [24] A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
    Chang, TT
    Gish, RG
    de Man, R
    Gadano, A
    Sollano, J
    Chao, YC
    Lok, AS
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    DeHertogh, D
    Wilber, R
    Colonno, R
    Apelian, D
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1001 - 1010
  • [25] Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2006, 45 (03) : 457 - 460
  • [26] Combination of Lamivudine and adefovir therapy in HBeAg-positive chronic hepatitis B patients with poor response to adefovir monotherapy
    Wang, L-C
    Chen, E-Q
    Cao, J.
    Liu, L.
    Wang, J-R
    Lei, B-J
    Tang, H.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (03) : 178 - 184
  • [27] Combination of peginterferon alfa-2b and lamivudine is superior to lamivudine alone in the treatment of chronic hepatitis B infection
    Sung, JJY
    Chan, HLY
    Hui, AY
    Wong, VWS
    Liew, CT
    Chim, AML
    Chan, FKL
    Hung, LCT
    Lee, YT
    Leung, NWY
    GASTROENTEROLOGY, 2004, 126 (04) : A682 - A682
  • [28] Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B
    Park, NH
    Shin, JW
    Park, JH
    Bang, SJ
    Kim, DH
    Joo, KR
    Kim, DH
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) : 216 - 221
  • [29] Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
    Marcellin, P
    Lau, GKK
    Bonino, F
    Farci, P
    Hadziyannis, S
    Jin, R
    Lu, ZM
    Piratvisuth, T
    Germanidis, G
    Yurdaydin, C
    Diago, M
    Gurel, S
    Lai, MY
    Button, P
    Pluck, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (12): : 1206 - 1217
  • [30] Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
    Sokal, EM
    Kelly, DA
    Mizerski, J
    Badia, IB
    Areias, JA
    Schwarz, KB
    Vegnente, A
    Little, NR
    Gardener, SD
    Jonas, MM
    HEPATOLOGY, 2006, 43 (02) : 225 - 232
12345